RxDoctor Payments Data

Sabrina Mackittrick, NP

Adult Health · New Hyde Park, NYNPI 1699196683

Payments from drug & device makers

$296in general payments, 2019–2025

Across 15 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$78
  • Novo Nordisk$57
  • Resmed Corp$28
  • Renalytix AI, Inc.$24
  • Shield Therapeutics Inc$21
  • Inspire Medical Systems, Inc.$21
  • plus $68 from 4 others

What the payments were for

  • Food & beverage$296100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$296 in reported general payments places this provider in the 45th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$52,602
Medicare patients
138
Services billed
827

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide19$37,958
FarxigaDapagliflozin Propanediol11$17,349
Rosuvastatin Calcium93$1,580
Albuterol Sulfate HfaAlbuterol Sulfate22$1,135
Levothyroxine Sodium48$842
SynthroidLevothyroxine Sodium13$828
Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril14$751
Valsartan18$662
Fluticasone Propionate30$556
Metoprolol Succinate42$511
Atorvastatin Calcium64$457
Telmisartan14$427
Levocetirizine Dihydrochloride28$399
Pantoprazole Sodium17$347
Famotidine32$335

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$57$37,95819 claims
AstraZenecaFarxiga$14$17,34911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,828 adult health providers in New York.

Other adult health in New Hyde Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →